基于“治未病”探析结直肠癌肝转移的研究进展  

Research Progress on Liver Metastasis of Colorectal Cancer based on"Preventive Treatment of Disease"

作　　者：高阳 守芳漾 万弘扬 方志军[1,2] GAO Yang;SHOU Fangyang;WAN Hongyang;FANG Zhijun(Nanjing Hospital of Integrated Traditional Chinese and Western Medicine,Jiangsu Nanjing 210038,China;Jiangsu Academy of Traditional Chinese Medicine,Jiangsu Nanjing 210038,China)

机构地区：[1]南京中医药大学附属中西医结合医院,江苏南京210028 [2]江苏省中医药研究院,江苏南京210028

出　　处：《中医药临床杂志》2023年第9期1831-1836,共6页Clinical Journal of Traditional Chinese Medicine

基　　金：江苏省中医药研究院重点项目(BE2021753);江苏省中医药研究院重点项目(JD2019SZXZD06)。

摘　　要：结直肠癌(colorectal cancer,CRC)作为第3大常见癌症,易发生远处转移。治疗上,西医以手术、放化疗、靶向等治疗为主,但不良反应大。而中医药对于CRC的防治和预后有多方向、不良反应低等特点,近年来,“治未病”理论多次应用于结直肠癌肝转移(colorectal cancer liver metastasis,CRC-LM)的防治,疗效突出,已得到广泛认可,在今后的临床诊疗中有相当广阔的前景。作者就“治未病”理论在CRC-LM的防治现状及前景进行综述。Colorectal cancer(CRC),as the third most common cancer,is prone to distant metastasis.In terms of treatment,Western medicine mainly focuses on surgery,radiotherapy and chemotherapy,and targeted treatments,but the side effects are severe.Traditional Chinese medicine has the characteristics of multi-directional prevention and prognosis of CRC,and low adverse reactions.The curative effect is outstanding,has been widely recognized,and has a very broad prospect in the future clinical diagnosis and treatment.The author reviews the current situation and prospects of the prevention and treatment of CRC-LM with the theory of“preventive treatment of diseases”.

关 键 词：结直肠癌 肝转移 治未病 益气健脾法 

分 类 号：R574.63[医药卫生—消化系统]